Frontiers In Allergy

Frontiers In Allergy

过敏前沿

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Frontiers In Allergy》是由Frontiers Media S.A.出版社创办的英文国际期刊(ISSN: 2673-6101),该期刊长期致力于过敏领域的创新研究,主要研究方向为Medicine-Infectious Diseases。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式以发表过敏领域等方向的原创性研究为核心(研究类文章占比68.72%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在179篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Frontiers In Allergy审稿周期约为12 Weeks。该刊近年未被列入国际预警名单,年发文量约179篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 179 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ALLERGY 过敏
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ALLERGY 过敏
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ALLERGY ESCI Q2 16 / 40

61.3

学科:ALLERGY ESCI Q2 18 / 40

56.25

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ALLERGY ESCI Q2 16 / 39

60.3

学科:ALLERGY ESCI Q2 18 / 39

55.13

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.3 SJR:0.874 SNIP:1.001
学科类别 分区 排名 百分位
大类:Medicine 小类:Infectious Diseases Q2 145 / 361

59%

大类:Medicine 小类:Immunology and Allergy Q3 129 / 234

45%

期刊发文

  • Toward personalized prediction: a multicenter machine learning model for omalizumab response duration in moderate-to-severe perennial allergic rhiniti

    Author: Miao, Ziqi; Dong, Lin; Liu, Jin; Li, Le; Dong, Xiang; Zhang, Shuchen; Zhu, Rongfei; Deng, Yuqin

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1784032

  • The relationship between allergic rhinitis and sleep disorders and mental healt

    Author: Feng, Xiaoning; Gu, Zhaowei; Wang, Yunxiu

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1806555

  • Treatment of toxic epidermal necrolysis in a patient with extensive skin damage induced by dimethyl N-cyanodithioiminocarbonate: a case repor

    Author: Tian, Xiaokun; Zhang, Kai; Qu, Yingwei; Xu, Bin; Cao, Kaixin; Wang, Cheng

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1765772

  • Management of life-threatening anaphylaxis to enzyme replacement therapy in an infant with Pompe disease: a case report and literature revie

    Author: Zhou, Jueru; Wang, Qian; Zhang, Han; Wang, Yuqi; Wang, Ziwei; Yang, Fan; Yang, Shiwei

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1757529

  • Multi-omics insights into dietary zinc-mediated reprogramming of the gut-nasal ecosystem in allergic rhiniti

    Author: Yan, Shiqi; Zhang, Zhijuan; Xia, Chunyan; Liu, Peng; Ma, Junbai; Liu, Jian; Wu, Tong; Wang, Hao; Ma, Ruixia

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1801629

  • PPARγ: a key orchestrator of epidermal barrier, immune responses, and lipid metabolism in atopic dermatitis pathogenesis and therap

    Author: Bao, Yuting; Xu, Kexin; Du, Yue; Feng, Meng; Li, Li; Li, Liangchang; Yan, Guanghai; Li, Xiaowan

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1780908

  • Clinical observation of stapokibart in patients under 18 years of age with seasonal allergic rhinitis: a case series study of 20 case

    Author: Wang, Long-fei; Ma, Wei-cong; Kan, Chen-xing; Hao, Guo-dong

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1785270

  • Advance in biologics for chronic rhinosinusitis with nasal polyp

    Author: Di, Yiming; Zeng, Ruizhi; Huang, Lei; Wu, Yong; Wu, Qingwu

    Journal: FRONTIERS IN ALLERGY. 2026; Vol. 7, Issue , pp. -. DOI: 10.3389/falgy.2026.1759649